Email
IZ Express #1,831: Immunize.org's 2025–26 influenza resources, Spanish PCV and PPSV VISs, and more
| From | Immunize.org <[email protected]> |
| Subject | IZ Express #1,831: Immunize.org's 2025–26 influenza resources, Spanish PCV and PPSV VISs, and more |
| Date | September 10, 2025 10:46 AM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
[link removed]
[link removed]
[link removed] [link removed]
Email not displaying correctly? View it in your browser ([link removed]).
[link removed]
Issue 1,831: September 10, 2025
Top Stories
* Immunize.org posts its up-to-date 2025–26 suite of influenza vaccination resources
* Immunize.org posts Spanish translations of both updated pneumococcal VISs
* Immunize.org updates zoster (shingles) Ask the Experts questions and answers
* Routine hepatitis B birth dose policies protect babies. Immunize.org’s Hepatitis B Birth Dose Honor Roll recognizes 593 institutions, including three new honorees.
* National Hispanic Heritage Month runs from September 15 to October 15; Immunize.org’s Spanish language resources support your Spanish-speaking patients
* Happy Mexican Independence Day, September 16! Here’s an orientation to vaccination information and advocacy in Mexico.
* “If a Mother Received Abrysvo RSV Vaccine During Pregnancy, Does the Infant Need RSV Preventive Antibody?” Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube.
* Journalists interview Immunize.org experts
* Vaccines in the news
Immunize.org Website and Clinical Resources
* Spotlight on the website: "Translations" web page simplifies access to our resources in 48 languages
* Recap: Immunize.org’s commitment to sharing clinical vaccination guidance based on the best available scientific evidence
* Recap: Immunize.org updates “Standing Orders for Administering Pfizer Respiratory Syncytial Virus (RSV) Vaccine (Abrysvo) During Pregnancy” to reference both preventive antibody options for infant RSV prevention
* Recap: Immunize.org updates “Meningococcal B Vaccine Recommendations by Age and Risk Factor” to include both pentavalent MenABCWY vaccine options
* Recap: Immunize.org updates resource “Before You Vaccinate Adults, Consider Their ‘H-A-L-O’!”
Featured Resources
* Association of Immunization Managers offers handout compiling a variety of useful influenza vaccination resources
* New web page from CHOP's Vaccine Education Center provides links to the latest science-based vaccine recommendations
* Needle anxiety is common at any age. Use Immunize.org’s clinical resources to offer a positive vaccination experience.
* Help Immunize.org reach more vaccinators through your social media networks. Follow us and share our posts on Facebook, Instagram, and LinkedIn!
Notable Publications
* “Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure—San Francisco, California, December 2024–January 2025” published in MMWR
Upcoming Events
* Today, virtual: Register for Immunize.org Website Office Hours. Join a 30-minute discussion about the VIS web section on September 10 at 4:00 p.m. (ET) or September 11 at 12:00 p.m. (ET). Recorded sessions archived.
* Virtual: Watch CDC’s webinar “Clinician Update on Measles Cases and Outbreaks in the United States” on September 11 at 2:00 p.m. (ET); CE credit offered
* Virtual: North Dakota State University Center for Immunization Research and Education hosts webinar titled “Science to Practice: Protecting Children from Respiratory Viruses in 2025–2026” on September 16 at 1:00 p.m. (ET); CE credit offered
* Virtual: September 18–19 ACIP meeting announced; discussion and possible votes on COVID-19, hepatitis B, MMRV, and RSV vaccines planned
------------------------------------------------------------
Top Stories
------------------------------------------------------------
Immunize.org posts its up-to-date 2025–26 suite of influenza vaccination resources
Immunize.org completed the annual review of our entire suite of influenza clinical resources for the 2025–26 season. All materials have a new date in the footnote to indicate they were reviewed and are current for the 2025–26 season, whether or not changes were necessary. These resources include:
* Screening Checklist for Contraindications to Injectable Influenza Vaccination ([link removed]): nontechnical edits were made and one URL was updated
* Screening Checklist for Contraindications to Live Attenuated Intranasal Influenza Vaccination ([link removed]): nontechnical edits were made and one URL was updated
* How to Administer Intranasal and Oral Vaccinations ([link removed]): vaccine administration language was clarified and one URL was updated
* How to Administer Intramuscular and Intranasal Influenza Vaccines ([link removed]): vaccine administration language was clarified and one URL was updated
* Communicating the Benefits of Influenza Vaccination ([link removed]): influenza disease burden and vaccination rates were updated (codeveloped with the Association of Immunization Managers)
* Not Sure If You Can Get an Influenza Vaccine? ([link removed]): reviewed, no changes
* Talking with Your Patient about Contraindications and Precautions to Influenza Vaccination ([link removed]): one URL was updated
* Influenza: Questions and Answers ([link removed]): disease burden data, ACIP thimerosal policy information, and URLs were updated
* Guide for Determining the Number of Doses of Influenza Vaccine to Give to Children Age 6 Months Through 8 Years ([link removed]): reviewed, no changes
* Don’t Take Chances with Your Family’s Health—Make Sure You All Get Vaccinated ([link removed]): reviewed, no changes
* Declination of Influenza Vaccination ([link removed]) : reviewed, no changes
These updated resources were announced in recent editions of IZ Express:
* Standing Orders for Administering Influenza Vaccine to Adults ([link removed]): updated to include information about thimerosal
* Standing Orders for Administering Influenza Vaccine to Children and Teens ([link removed]): updated to include information about thimerosal
* Influenza Vaccine Products for the 2025–2026 Influenza Season ([link removed]): updated to include 2025–26 licensed products, note about variable multidose vial availability added
Find all of our influenza vaccine resources for the 2025–26 season at the Vaccines A–Z: Influenza ([link removed]) main page.
Related Links
* Immunize.org: Vaccines A–Z: Influenza ([link removed]) web page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
------------------------------------------------------------
Immunize.org posts Spanish translations of both updated pneumococcal VISs
Immunize.org posted Spanish translations of the two current pneumococcal VISs that were updated by CDC on May 29, 2025.
* PCV (Pneumococcal Conjugate) Vaccine VIS ([link removed])
(view in RTF ([link removed])
and English ([link removed]) )
* PPSV (Pneumococcal Polysaccharide) Vaccine VIS ([link removed])
(view in RTF ([link removed])
and English ([link removed]) )
[link removed] [link removed]
To locate VIS translations for a particular vaccine, click on “Vaccines & VISs” at Immunize.org, click on “VISs,” and then select a specific vaccine. Scrolling down the resulting page, you will see the current English VIS (the official federal version), followed by a list of translations of the current English version. Where applicable, current translations are followed by a list of translations of past English versions that are still usable because they are the most recent translations available in those languages. When a patient is given any VIS translation, they should also receive the current official VIS, which is in English. Additional tips on using VISs appear at the bottom of the web page.
Check the version date of your inventory of VIS translations. Discard translations of previous versions as translations of current versions become available.
Related Links
* Immunize.org: Vaccine & VISs: Translations ([link removed]) main page for access to all translations of VISs
* Immunize.org: Clinical Resources: VIS-related Resources ([link removed]) web page
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Immunize.org updates zoster (shingles) Ask the Experts questions and answers
Immunize.org’s team of experts reviewed and updated all questions and answers in Ask the Experts: Zoster (Shingles) ([link removed]). There have been no changes to federal recommendations for the use of recombinant zoster vaccine (RZV, Shingrix, GSK) since the previous update in 2022.
Changes added specific criteria for a healthcare provider-verified history of varicella disease, and information about the manufacturer-filled syringe (MFS) presentation. The MFS is now available in addition to the presentation that requires reconstitution. Hyperlinks were added or updated as needed. No new questions were added.
Immunize.org’s Ask the Experts ([link removed]) main page leads you to 30 web pages on various topics with more than 1,300 common or challenging questions and answers about vaccines and their administration. Immunize.org’s team of experts includes Kelly L. Moore, MD, MPH (team lead); Carolyn B. Bridges, MD, FACP; Iyabode Beysolow, MD, MPH; and Jane Zucker, MD, MSC.
Related Links
* Immunize.org: Ask the Experts ([link removed]) main page with more than 1,300 questions and answers
* Immunize.org: Ask the Experts: Zoster (Shingles) ([link removed]) web page
* Immunize.org: Standing Orders for Administering Recombinant Zoster Vaccine (Shingrix) to Adults ([link removed]) (PDF)
------------------------------------------------------------
Routine hepatitis B birth dose policies protect babies. Immunize.org’s Hepatitis B Birth Dose Honor Roll recognizes 593 institutions, including three new honorees.
Hepatitis B (HepB) vaccination is extremely effective during infancy, protecting about 98% of healthy, term infants. Transmission of hepatitis B virus (HBV) during infancy results in chronic, lifelong infection for about 9 in 10 babies, with one in four of them going on to develop cirrhosis or liver cancer in adulthood. Vaccination and use of hepatitis B immune globulin (HBIG) for infants born to HBV test-positive mothers (and mothers of unknown status) reduces the risk of HBV transmission by 94%; vaccination alone, given on the day of birth, reduces the risk by 75%.
To ensure no child is missed, the birth dose of HepB was first recommended for all U.S.-born infants in 2005. ACIP specified that the dose of HepB should be given within 24 hours of life in 2016, to better assure protection of any newborn with an unrecognized exposure to HBV. Since 2013, Immunize.org has recognized and honored 593 birthing institutions that have established policies and practices ensuring that at least 90% of infants born receive a dose of HepB vaccine before going home. These policies and practices represent a critical safety net to protect newborns from the lifelong consequences of early HBV infection.
Immunize.org is pleased to welcome three new institutions into its Hepatitis B Birth Dose Honor Roll ([link removed](healthcare)), which now recognizes 593 honorees. The new birthing institutions appear below with their reported hepatitis B birth dose coverage rates in parentheses.
* Health Alliance Hospital, Kingston, NY (90%)
* Henry Community Health, New Castle, IN (97%)
* Indiana University Health Bloomington Hospital, Bloomington, IN (92%)
Please join us in recognizing this honoree with a decade of sustained excellence:
* Oneida Health, Oneida, NY (90%) (10 years)
The Honor Roll includes birthing institutions from 50 states, the District of Columbia, American Samoa, Guam, Puerto Rico, Northern Mariana Islands, and U.S. military hospitals overseas.
The Honor Roll is a key part of Immunize.org’s initiative urging U.S. hospitals to Give Birth to the End of Hep B ([link removed]). Hospitals and birthing centers are recognized for attaining high coverage for hepatitis B vaccine at birth and meeting additional criteria. The How to Apply ([link removed]) web page provides information on the criteria for inclusion in the Hepatitis B Birth Dose Honor Role and the application form.
Honorees receive an 8.5" x 11" color certificate suitable for printing and framing. Their acceptance is announced through Immunize.org’s social media channels and to IZ Express’s readers.
Please visit the Hepatitis B Birth Dose Honor Roll web page that lists these institutions and celebrates their vigorous efforts to protect infants from perinatal hepatitis B transmission.
Related Immunize.org Resources
* Give Birth to the End of Hep B ([link removed]) main page
* Hepatitis B Birth Dose Honor Roll ([link removed](healthcare)) web page
------------------------------------------------------------
National Hispanic Heritage Month runs from September 15 to October 15; Immunize.org’s Spanish language resources support your Spanish-speaking patients
National Hispanic Heritage Month ([link removed]), observed from September 15 to October 15, celebrates the histories, cultures, and contributions of Americans whose ancestors came from Spain and elsewhere in the Americas.
Immunize.org offers a variety of resources in Spanish, including translated resources for patients and healthcare personnel ([link removed]) and Spanish-language VISs ([link removed]). Use the filter-by-language feature or go to our Clinical Resources Translations page and simply select the Spanish language clinical resources or VIS link to see everything offered in Spanish.
In addition to Immunize.org resources, our newest website, LetsGetRealAboutVaccines.org, has a Spanish language version of the site (Hablemos En Serio ([link removed]) ) and all its resources.
Related Links
* National Hispanic Heritage Month ([link removed]) website
* Immunize.org: VIS Translations: Spanish ([link removed]) main page
* Immunize.org: Clinical Resources: Spanish Translations ([link removed]) main page
* LetsGetRealAboutVaccines.org: Hablemos En Serio ([link removed])
------------------------------------------------------------
Happy Mexican Independence Day, September 16! Here’s an orientation to vaccination information and advocacy in Mexico.
¡Viva México! September 16 is the 214th anniversary of Mexico’s independence. We celebrate our neighbors by sharing select Mexican resources for vaccination information and advocacy.
Expert committees:
* Consejo Nacional de Vacunación (CONAVA) ([link removed]), National Advisory Committee for Vaccination, counterpart to ACIP
Advocacy groups and resources:
* Asociación Mexicana de Vacunología ([link removed])
* Alianza por la Vacunación ([link removed])
Helpful resources:
* Boletín Epidemiológico ([link removed]): Sistema Nacional de Vigilancia Epidemiológica Sistema Único de Información (Epidemiological Bulletin: National Epidemiological Surveillance System Unique Information System), counterpart to MMWR
* Lineamientos Generales del Programa de Vacunación Universal y Jornadas de Salud Pública 2020 ([link removed]) (General Guidelines of the Universal Vaccination Program and Public Health Conference 2020)
* Esquema Nacional de Vacunación ([link removed]) (routine vaccination schedule)
Government institutions:
* Programa Nacional de Vacunación ([link removed]) (National Vaccination Program)
* Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) ([link removed]) (Federal Commission for Protection Against Health Risks), counterpart to FDA
* Vacunas Autorizadas en México Incluyendo Fichas Tecnicas (Vaccines Authorized in Mexico, Including Technical Sheets)
Best wishes to all our friends delivering vaccinations to the people of Mexico!
------------------------------------------------------------
“If a Mother Received Abrysvo RSV Vaccine During Pregnancy, Does the Infant Need RSV Preventive Antibody?” Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube.
This week, our featured episode from the Ask the Experts Video Series is titled If a Mother Received Abrysvo RSV Vaccine During Pregnancy, Does the Infant Need RSV Preventive Antibody? ([link removed]) For infants younger than age 8 months, the recommendation is to only administer RSV preventive antibody product if the mother was not vaccinated, or not effectively vaccinated, with Abrysvo (Pfizer) brand of RSV vaccine during pregnancy. Maternal vaccination should be considered ineffective if, for example, the infant was born less than 14 days after maternal vaccination or if Arexvy (GSK) brand of RSV vaccine was given during pregnancy.
The 1-minute video is available on our YouTube channel ([link removed]), along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])
------------------------------------------------------------
Journalists interview Immunize.org experts
Journalists seek out Immunize.org experts to help explain vaccines to the public and policy makers. We help the media understand and communicate the complex work vaccinators do. Here is a selection of our recent citations.
* STAT: Fired Members of the CDC Vaccine Advisory Committee: Americans Are Losing the Ability to Choose Vaccination (commentary) ([link removed]) (9/4/25)
* CNN: Florida Plans to End Vaccine Mandates Statewide, Including for Schoolchildren ([link removed]) (9/3/25)
* Washington Post: FDA Questions Common Practice of Getting COVID, Flu Vaccines Together ([link removed]) (9/3/25)
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* New York Times: Whistle-Blower Complaints Detail Tension Over Vaccines at N.I.H. ([link removed]) (9/4/25)
* Axios: Massachusetts Becomes First State to Impose Its Own Vaccine Coverage Rules ([link removed]) (9/4/25)
* WHYY: Pennsylvania Pharmacies Can Now Offer New COVID Vaccines After State Adopts Recommendations from Medical Societies ([link removed]) (9/3/25)
* New York Times: States Go Their Own (and Contradictory) Ways on Vaccine Policy ([link removed]) (9/3/25)
------------------------------------------------------------
Immunize.org Website and Clinical Resources
------------------------------------------------------------
Spotlight on the website: "Translations" web page simplifies access to our resources in 48 languages
Immunize.org offers translations of VISs and popular Patient Handouts. Our Translations web page ([link removed]) provides quick access to every translated resource on the Immunize.org website. Translations of one or more documents are available in 48 languages.
Languages are listed alphabetically in a simple table format. Next to the desired language, select either “VISs” or “Clinical Resources” to view all documents available in that language.
This "Translations" page is accessible from two menus at the top of each page: either the “Vaccines & VISs” or “Clinical Resources” menu. The direct link is www.immunize.org/translations ([link removed]).
Patients benefit from having vaccine information in their preferred language. Immunize.org's "Translations" page makes it easier for you to meet their needs.
------------------------------------------------------------
Recap: Immunize.org’s commitment to sharing clinical vaccination guidance based on the best available scientific evidence
The recent changes to the membership of ACIP and resignation of respected scientific leaders at CDC have raised serious concerns across public health and healthcare communities. Information shared by the departing CDC leaders has raised doubts about the scientific validity of vaccine policies contemplated by the current administration. In addition, we observed the June ACIP vote against the use of thimerosal-containing influenza vaccines, a decision made without following the standard rigorous review of available data or the structured evidence-to-recommendations framework. In response, professional medical societies (e.g., American Academy of Pediatrics, American College of Obstetricians and Gynecologists) have begun to issue vaccination guidance that differs from new CDC guidance. Vaccination providers and educators who depend on Immunize.org resources should understand how we are approaching this unprecedented situation.
First, Immunize.org will continue to ensure vaccination providers know what CDC and ACIP recommend. Their recommendations directly affect VFC, Medicaid, and Medicare vaccine coverage, and could impact other insurance plan coverage. Federal recommendations may also define the permitted scope of practice for some vaccinators, including pharmacists, depending upon state regulations. We will provide context to help our readers understand when available scientific evidence does not support federal guidance.
Second, we will continue to educate vaccinators and share the best available evidence-based clinical information and guidance for vaccination. This may include adding links to the recommendations and published schedules of professional societies or other broadly accepted clinical guidance organizations. When we update resources with guidance from other credible scientific sources, we will be explicit about where that guidance came from and connect you to those sources.
Our goal is to support you to be able to make the best possible clinical practice decisions and provide the best available vaccination advice to your patients and families. To this end, our popular standing orders templates will include CDC recommendations and, when needed, refer to major professional society recommendations where there are important differences. As always, our standing orders templates should be adapted as needed to develop the standing orders you use in specific settings.
Immunize.org is in the process of determining the best ways to reflect these differences on our website clearly and concisely. We commit to keeping you, our readers and partners, informed as we proceed. We remain committed to supporting you and members of the public with trustworthy vaccination information and resources.
------------------------------------------------------------
Recap: Immunize.org updates “Standing Orders for Administering Pfizer Respiratory Syncytial Virus (RSV) Vaccine (Abrysvo) During Pregnancy” to reference both preventive antibody options for infant RSV prevention
Immunize.org updated its Standing Orders for Administering Pfizer Respiratory Syncytial Virus (RSV) Vaccine (Abrysvo) During Pregnancy ([link removed]), to note the options to use nirsevimab (Beyfortus, Sanofi ([link removed]) ) or clesrovimab (Enflonsia, Merck) ([link removed]) for infant RSV protection if the mother was not effectively vaccinated during her pregnancy.
------------------------------------------------------------
Recap: Immunize.org updates “Meningococcal B Vaccine Recommendations by Age and Risk Factor” to include both pentavalent MenABCWY vaccine options
Immunize.org updated Meningococcal B Vaccine Recommendations by Age and Risk Factor ([link removed]) to add the second pentavalent MenABCWY vaccine (Penmenvy, GSK ([link removed]) [link removed]) in addition to Penbraya (Pfizer).
------------------------------------------------------------
Recap: Immunize.org updates resource “Before You Vaccinate Adults, Consider Their ‘H-A-L-O’!”
Immunize.org recently updated its popular resource for healthcare professionals titled Before You Vaccinate Adults, Consider Their “H-A-L-O” ([link removed])!
H-A-L-O refers to four factors:
* Health condition
* Age
* Lifestyle
* Occupation
Edits incorporate the age 50 threshold for adults with risk factors to receive RSV vaccine and referral to current recommendations for COVID-19 vaccine.
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Association of Immunization Managers offers handout compiling a variety of useful influenza vaccination resources
The Association of Immunization Managers ([link removed]) (AIM) posted Connecting the Dots: Influenza Vaccinations ([link removed]), a one-page resource guide designed to support influenza vaccination efforts. It conveniently lists several tools, helping users quickly access what they need. It is organized into three categories: health education, health communication, and program planning.
Connecting the Dots ([link removed]) will be updated monthly.
To find influenza resources from Immunize.org, see the Vaccines A–Z: Influenza ([link removed]) web page.
------------------------------------------------------------
New web page from CHOP's Vaccine Education Center provides links to the latest science-based vaccine recommendations
Children's Hospital of Philadelphia's ([link removed]) Vaccine Education Center ([link removed]) launched a new web page, Locating the Latest Science-Based Vaccine Recommendations ([link removed]), to assist in staying abreast of the latest science-based recommendations.
This one-stop web page ([link removed]) will be updated as recommendations change or as new statements from professional societies become available.
------------------------------------------------------------
Needle anxiety is common at any age. Use Immunize.org’s clinical resources to offer a positive vaccination experience.
In Clinical Resources: Improving the Vaccination Experience ([link removed]), Immunize.org provides print and video tools to create a positive vaccination experience and ease injection anxiety in children and adults. Links to additional resources from trusted partner organizations are also provided.
The web page links to eight printable resources ([link removed]) on addressing vaccination anxiety (four for providers, four for recipients—also available in Spanish), two in-depth webinars, and six brief videos (listed below). As with all Immunize.org resources, these are free to download, link, copy, and share.
The video topics include:
* How to Administer Multiple Intramuscular Vaccines to Adults During One Visit ([link removed])
* Using Enhanced Screening Checklists for Contraindications to Vaccination ([link removed])
* Addressing Vaccination Anxiety for Infants: Strategies for Vaccine Recipients and Caregivers ([link removed])
* Addressing Vaccination Anxiety: Strategies for Healthcare Professionals ([link removed])
* Fainting Related to Vaccination: What You Need to Know ([link removed])
* Addressing Vaccination Anxiety for Children: Strategies for Vaccine Recipients and Caregivers ([link removed])
Related Link
* Immunize.org: Clinical Resources: Improving the Vaccination Experience ([link removed]) web page
------------------------------------------------------------
Help Immunize.org reach more vaccinators through your social media networks. Follow us and share our posts on Facebook, Instagram, and LinkedIn!
Immunize.org offers a social media program to highlight our educational resources for a widespread audience of vaccinators. Our social media channels now feature our most popular printable resources and Ask the Experts questions, as well as announcements important to frontline vaccinators. Please view and share our newest feature, the Ask the Experts Video Series ([link removed]).
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise:
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at Immunize.org ([link removed])
* YouTube at ImmunizeOrg ([link removed])
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
“Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure—San Francisco, California, December 2024–January 2025” published in MMWR
CDC published Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure—San Francisco, California, December 2024–January 2025 ([link removed]) on September 4 in MMWR. A portion of the summary appears below.
As of January 1, 2025, 37 human cases of highly pathogenic avian influenza (HPAI) A(H5N1) had been detected in California, none of which occurred in San Francisco. . . .
On January 9, 2025, a case of HPAI A(H5N1) infection was identified in a school-aged child in San Francisco through enhanced surveillance (influenza A virus subtyping of a sample of specimens weekly). No source of exposure was identified, and investigations found no laboratory evidence of human-to-human transmission among close contacts. . . .
Enhanced surveillance and timely subtyping of a subset of influenza A–positive specimens, including specimens from persons without known A(H5N1) exposure, are important to detect avian influenza A virus infections. Public health investigations are critical to monitoring for human-to-human transmission.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]).
Related Link
* CDC: MMWR main page ([link removed]) providing access to the MMWR family of publications
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Today, virtual: Register for Immunize.org Website Office Hours. Join a 30-minute discussion about the VIS web section on September 10 at 4:00 p.m. (ET) or September 11 at 12:00 p.m. (ET). Recorded sessions archived.
To learn simple tips and tricks for using our website efficiently, please register for our next set of Website Office Hours on Wednesday, September 10, at 4:00 p.m. (ET) ([link removed]) or Thursday, September 11, at 12:00 p.m. (ET) ([link removed]). The same content will be covered in both sessions.
We will open each 30-minute session with a short, live demonstration on navigating the popular VIS website section on Immunize.org. You can submit questions when you register or live on Zoom during the session.
Register today for Immunize.org Website Office Hours (content is the same for both):
* Wednesday, September 10, at 4:00 p.m. (ET) ([link removed])
* Thursday, September 11, at 12:00 p.m. (ET) ([link removed])
The archive of previous Website Office Hours content ([link removed]) is posted at Immunize.org’s "Webinars & Videos" page.
Mark your calendar ([link removed]) for future Immunize.org Website Office Hours.
------------------------------------------------------------
Virtual: Watch CDC’s webinar “Clinician Update on Measles Cases and Outbreaks in the United States” on September 11 at 2:00 p.m. (ET); CE credit offered
CDC will host a 1-hour Clinician Outreach and Communication Activity (COCA) call titled Clinician Update on Measles Cases and Outbreaks in the United States ([link removed]) at 2:00 p.m. (ET) on September 11. Presenters will discuss the current epidemiology of measles in the United States and address common clinical questions about preventing, identifying, and testing for measles. Presenters will summarize MMR vaccination recommendations and considerations.
A recording of the COCA presentation will be archived on the COCA Calls web page ([link removed]).
Free CE credit (including CME, CPE, and CNE) will be offered for this COCA call.
------------------------------------------------------------
Virtual: North Dakota State University Center for Immunization Research and Education hosts webinar titled “Science to Practice: Protecting Children from Respiratory Viruses in 2025–2026” on September 16 at 1:00 p.m. (ET); CE credit offered
The North Dakota State University Center for Immunization Research and Education will host a webinar titled Science to Practice: Protecting Children from Respiratory Viruses in 2025–2026 ([link removed]), from 1:00 p.m. (ET) on September 16. This webinar will explore the latest trends in RSV, influenza, and COVID-19 in children, highlighting both established patterns and emerging threats.
Participants will gain insight into the key risk factors and vulnerable pediatric populations most at risk for severe outcomes, helping clinicians anticipate and manage complex cases with greater precision. Evidence-based prevention methods and current clinical recommendations will be discussed.
Free CME and CPE will be provided to live attendees.
Register for the webinar ([link removed]).
------------------------------------------------------------
Virtual: September 18–19 ACIP meeting announced; discussion and possible votes on COVID-19, hepatitis B, MMRV, and RSV vaccines planned
CDC is scheduled to convene the ACIP on September 18–19 ([link removed]). Based on ahttps://public-inspection.federalregister.gov/2025-16706.pdfnotice in the Federal Register ([link removed]), the meeting will discuss and potentially vote on COVID-19, hepatitis B, and MMRV vaccines and RSV preventive antibody products. An agenda has not yet been posted.
Written public comments ([link removed]) and registration for oral public comments must be received between September 2–13.
No registration is required to watch webcasts of live ACIP meetings or listen via telephone.
Related Links
* CDC: ACIP main page ([link removed]) for access to webcast, agendas
* CDC: ACIP Meeting Information ([link removed]) for presentation slides, content from previous meetings, and information about future meetings
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]).
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Gräbenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]).
IZ Express is supported in part by Grant No. NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer (http:// [link removed])
ISSN: 2771-8085
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
[link removed]
[link removed] [link removed]
Email not displaying correctly? View it in your browser ([link removed]).
[link removed]
Issue 1,831: September 10, 2025
Top Stories
* Immunize.org posts its up-to-date 2025–26 suite of influenza vaccination resources
* Immunize.org posts Spanish translations of both updated pneumococcal VISs
* Immunize.org updates zoster (shingles) Ask the Experts questions and answers
* Routine hepatitis B birth dose policies protect babies. Immunize.org’s Hepatitis B Birth Dose Honor Roll recognizes 593 institutions, including three new honorees.
* National Hispanic Heritage Month runs from September 15 to October 15; Immunize.org’s Spanish language resources support your Spanish-speaking patients
* Happy Mexican Independence Day, September 16! Here’s an orientation to vaccination information and advocacy in Mexico.
* “If a Mother Received Abrysvo RSV Vaccine During Pregnancy, Does the Infant Need RSV Preventive Antibody?” Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube.
* Journalists interview Immunize.org experts
* Vaccines in the news
Immunize.org Website and Clinical Resources
* Spotlight on the website: "Translations" web page simplifies access to our resources in 48 languages
* Recap: Immunize.org’s commitment to sharing clinical vaccination guidance based on the best available scientific evidence
* Recap: Immunize.org updates “Standing Orders for Administering Pfizer Respiratory Syncytial Virus (RSV) Vaccine (Abrysvo) During Pregnancy” to reference both preventive antibody options for infant RSV prevention
* Recap: Immunize.org updates “Meningococcal B Vaccine Recommendations by Age and Risk Factor” to include both pentavalent MenABCWY vaccine options
* Recap: Immunize.org updates resource “Before You Vaccinate Adults, Consider Their ‘H-A-L-O’!”
Featured Resources
* Association of Immunization Managers offers handout compiling a variety of useful influenza vaccination resources
* New web page from CHOP's Vaccine Education Center provides links to the latest science-based vaccine recommendations
* Needle anxiety is common at any age. Use Immunize.org’s clinical resources to offer a positive vaccination experience.
* Help Immunize.org reach more vaccinators through your social media networks. Follow us and share our posts on Facebook, Instagram, and LinkedIn!
Notable Publications
* “Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure—San Francisco, California, December 2024–January 2025” published in MMWR
Upcoming Events
* Today, virtual: Register for Immunize.org Website Office Hours. Join a 30-minute discussion about the VIS web section on September 10 at 4:00 p.m. (ET) or September 11 at 12:00 p.m. (ET). Recorded sessions archived.
* Virtual: Watch CDC’s webinar “Clinician Update on Measles Cases and Outbreaks in the United States” on September 11 at 2:00 p.m. (ET); CE credit offered
* Virtual: North Dakota State University Center for Immunization Research and Education hosts webinar titled “Science to Practice: Protecting Children from Respiratory Viruses in 2025–2026” on September 16 at 1:00 p.m. (ET); CE credit offered
* Virtual: September 18–19 ACIP meeting announced; discussion and possible votes on COVID-19, hepatitis B, MMRV, and RSV vaccines planned
------------------------------------------------------------
Top Stories
------------------------------------------------------------
Immunize.org posts its up-to-date 2025–26 suite of influenza vaccination resources
Immunize.org completed the annual review of our entire suite of influenza clinical resources for the 2025–26 season. All materials have a new date in the footnote to indicate they were reviewed and are current for the 2025–26 season, whether or not changes were necessary. These resources include:
* Screening Checklist for Contraindications to Injectable Influenza Vaccination ([link removed]): nontechnical edits were made and one URL was updated
* Screening Checklist for Contraindications to Live Attenuated Intranasal Influenza Vaccination ([link removed]): nontechnical edits were made and one URL was updated
* How to Administer Intranasal and Oral Vaccinations ([link removed]): vaccine administration language was clarified and one URL was updated
* How to Administer Intramuscular and Intranasal Influenza Vaccines ([link removed]): vaccine administration language was clarified and one URL was updated
* Communicating the Benefits of Influenza Vaccination ([link removed]): influenza disease burden and vaccination rates were updated (codeveloped with the Association of Immunization Managers)
* Not Sure If You Can Get an Influenza Vaccine? ([link removed]): reviewed, no changes
* Talking with Your Patient about Contraindications and Precautions to Influenza Vaccination ([link removed]): one URL was updated
* Influenza: Questions and Answers ([link removed]): disease burden data, ACIP thimerosal policy information, and URLs were updated
* Guide for Determining the Number of Doses of Influenza Vaccine to Give to Children Age 6 Months Through 8 Years ([link removed]): reviewed, no changes
* Don’t Take Chances with Your Family’s Health—Make Sure You All Get Vaccinated ([link removed]): reviewed, no changes
* Declination of Influenza Vaccination ([link removed]) : reviewed, no changes
These updated resources were announced in recent editions of IZ Express:
* Standing Orders for Administering Influenza Vaccine to Adults ([link removed]): updated to include information about thimerosal
* Standing Orders for Administering Influenza Vaccine to Children and Teens ([link removed]): updated to include information about thimerosal
* Influenza Vaccine Products for the 2025–2026 Influenza Season ([link removed]): updated to include 2025–26 licensed products, note about variable multidose vial availability added
Find all of our influenza vaccine resources for the 2025–26 season at the Vaccines A–Z: Influenza ([link removed]) main page.
Related Links
* Immunize.org: Vaccines A–Z: Influenza ([link removed]) web page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
------------------------------------------------------------
Immunize.org posts Spanish translations of both updated pneumococcal VISs
Immunize.org posted Spanish translations of the two current pneumococcal VISs that were updated by CDC on May 29, 2025.
* PCV (Pneumococcal Conjugate) Vaccine VIS ([link removed])
(view in RTF ([link removed])
and English ([link removed]) )
* PPSV (Pneumococcal Polysaccharide) Vaccine VIS ([link removed])
(view in RTF ([link removed])
and English ([link removed]) )
[link removed] [link removed]
To locate VIS translations for a particular vaccine, click on “Vaccines & VISs” at Immunize.org, click on “VISs,” and then select a specific vaccine. Scrolling down the resulting page, you will see the current English VIS (the official federal version), followed by a list of translations of the current English version. Where applicable, current translations are followed by a list of translations of past English versions that are still usable because they are the most recent translations available in those languages. When a patient is given any VIS translation, they should also receive the current official VIS, which is in English. Additional tips on using VISs appear at the bottom of the web page.
Check the version date of your inventory of VIS translations. Discard translations of previous versions as translations of current versions become available.
Related Links
* Immunize.org: Vaccine & VISs: Translations ([link removed]) main page for access to all translations of VISs
* Immunize.org: Clinical Resources: VIS-related Resources ([link removed]) web page
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Immunize.org updates zoster (shingles) Ask the Experts questions and answers
Immunize.org’s team of experts reviewed and updated all questions and answers in Ask the Experts: Zoster (Shingles) ([link removed]). There have been no changes to federal recommendations for the use of recombinant zoster vaccine (RZV, Shingrix, GSK) since the previous update in 2022.
Changes added specific criteria for a healthcare provider-verified history of varicella disease, and information about the manufacturer-filled syringe (MFS) presentation. The MFS is now available in addition to the presentation that requires reconstitution. Hyperlinks were added or updated as needed. No new questions were added.
Immunize.org’s Ask the Experts ([link removed]) main page leads you to 30 web pages on various topics with more than 1,300 common or challenging questions and answers about vaccines and their administration. Immunize.org’s team of experts includes Kelly L. Moore, MD, MPH (team lead); Carolyn B. Bridges, MD, FACP; Iyabode Beysolow, MD, MPH; and Jane Zucker, MD, MSC.
Related Links
* Immunize.org: Ask the Experts ([link removed]) main page with more than 1,300 questions and answers
* Immunize.org: Ask the Experts: Zoster (Shingles) ([link removed]) web page
* Immunize.org: Standing Orders for Administering Recombinant Zoster Vaccine (Shingrix) to Adults ([link removed]) (PDF)
------------------------------------------------------------
Routine hepatitis B birth dose policies protect babies. Immunize.org’s Hepatitis B Birth Dose Honor Roll recognizes 593 institutions, including three new honorees.
Hepatitis B (HepB) vaccination is extremely effective during infancy, protecting about 98% of healthy, term infants. Transmission of hepatitis B virus (HBV) during infancy results in chronic, lifelong infection for about 9 in 10 babies, with one in four of them going on to develop cirrhosis or liver cancer in adulthood. Vaccination and use of hepatitis B immune globulin (HBIG) for infants born to HBV test-positive mothers (and mothers of unknown status) reduces the risk of HBV transmission by 94%; vaccination alone, given on the day of birth, reduces the risk by 75%.
To ensure no child is missed, the birth dose of HepB was first recommended for all U.S.-born infants in 2005. ACIP specified that the dose of HepB should be given within 24 hours of life in 2016, to better assure protection of any newborn with an unrecognized exposure to HBV. Since 2013, Immunize.org has recognized and honored 593 birthing institutions that have established policies and practices ensuring that at least 90% of infants born receive a dose of HepB vaccine before going home. These policies and practices represent a critical safety net to protect newborns from the lifelong consequences of early HBV infection.
Immunize.org is pleased to welcome three new institutions into its Hepatitis B Birth Dose Honor Roll ([link removed](healthcare)), which now recognizes 593 honorees. The new birthing institutions appear below with their reported hepatitis B birth dose coverage rates in parentheses.
* Health Alliance Hospital, Kingston, NY (90%)
* Henry Community Health, New Castle, IN (97%)
* Indiana University Health Bloomington Hospital, Bloomington, IN (92%)
Please join us in recognizing this honoree with a decade of sustained excellence:
* Oneida Health, Oneida, NY (90%) (10 years)
The Honor Roll includes birthing institutions from 50 states, the District of Columbia, American Samoa, Guam, Puerto Rico, Northern Mariana Islands, and U.S. military hospitals overseas.
The Honor Roll is a key part of Immunize.org’s initiative urging U.S. hospitals to Give Birth to the End of Hep B ([link removed]). Hospitals and birthing centers are recognized for attaining high coverage for hepatitis B vaccine at birth and meeting additional criteria. The How to Apply ([link removed]) web page provides information on the criteria for inclusion in the Hepatitis B Birth Dose Honor Role and the application form.
Honorees receive an 8.5" x 11" color certificate suitable for printing and framing. Their acceptance is announced through Immunize.org’s social media channels and to IZ Express’s readers.
Please visit the Hepatitis B Birth Dose Honor Roll web page that lists these institutions and celebrates their vigorous efforts to protect infants from perinatal hepatitis B transmission.
Related Immunize.org Resources
* Give Birth to the End of Hep B ([link removed]) main page
* Hepatitis B Birth Dose Honor Roll ([link removed](healthcare)) web page
------------------------------------------------------------
National Hispanic Heritage Month runs from September 15 to October 15; Immunize.org’s Spanish language resources support your Spanish-speaking patients
National Hispanic Heritage Month ([link removed]), observed from September 15 to October 15, celebrates the histories, cultures, and contributions of Americans whose ancestors came from Spain and elsewhere in the Americas.
Immunize.org offers a variety of resources in Spanish, including translated resources for patients and healthcare personnel ([link removed]) and Spanish-language VISs ([link removed]). Use the filter-by-language feature or go to our Clinical Resources Translations page and simply select the Spanish language clinical resources or VIS link to see everything offered in Spanish.
In addition to Immunize.org resources, our newest website, LetsGetRealAboutVaccines.org, has a Spanish language version of the site (Hablemos En Serio ([link removed]) ) and all its resources.
Related Links
* National Hispanic Heritage Month ([link removed]) website
* Immunize.org: VIS Translations: Spanish ([link removed]) main page
* Immunize.org: Clinical Resources: Spanish Translations ([link removed]) main page
* LetsGetRealAboutVaccines.org: Hablemos En Serio ([link removed])
------------------------------------------------------------
Happy Mexican Independence Day, September 16! Here’s an orientation to vaccination information and advocacy in Mexico.
¡Viva México! September 16 is the 214th anniversary of Mexico’s independence. We celebrate our neighbors by sharing select Mexican resources for vaccination information and advocacy.
Expert committees:
* Consejo Nacional de Vacunación (CONAVA) ([link removed]), National Advisory Committee for Vaccination, counterpart to ACIP
Advocacy groups and resources:
* Asociación Mexicana de Vacunología ([link removed])
* Alianza por la Vacunación ([link removed])
Helpful resources:
* Boletín Epidemiológico ([link removed]): Sistema Nacional de Vigilancia Epidemiológica Sistema Único de Información (Epidemiological Bulletin: National Epidemiological Surveillance System Unique Information System), counterpart to MMWR
* Lineamientos Generales del Programa de Vacunación Universal y Jornadas de Salud Pública 2020 ([link removed]) (General Guidelines of the Universal Vaccination Program and Public Health Conference 2020)
* Esquema Nacional de Vacunación ([link removed]) (routine vaccination schedule)
Government institutions:
* Programa Nacional de Vacunación ([link removed]) (National Vaccination Program)
* Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) ([link removed]) (Federal Commission for Protection Against Health Risks), counterpart to FDA
* Vacunas Autorizadas en México Incluyendo Fichas Tecnicas (Vaccines Authorized in Mexico, Including Technical Sheets)
Best wishes to all our friends delivering vaccinations to the people of Mexico!
------------------------------------------------------------
“If a Mother Received Abrysvo RSV Vaccine During Pregnancy, Does the Infant Need RSV Preventive Antibody?” Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube.
This week, our featured episode from the Ask the Experts Video Series is titled If a Mother Received Abrysvo RSV Vaccine During Pregnancy, Does the Infant Need RSV Preventive Antibody? ([link removed]) For infants younger than age 8 months, the recommendation is to only administer RSV preventive antibody product if the mother was not vaccinated, or not effectively vaccinated, with Abrysvo (Pfizer) brand of RSV vaccine during pregnancy. Maternal vaccination should be considered ineffective if, for example, the infant was born less than 14 days after maternal vaccination or if Arexvy (GSK) brand of RSV vaccine was given during pregnancy.
The 1-minute video is available on our YouTube channel ([link removed]), along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])
------------------------------------------------------------
Journalists interview Immunize.org experts
Journalists seek out Immunize.org experts to help explain vaccines to the public and policy makers. We help the media understand and communicate the complex work vaccinators do. Here is a selection of our recent citations.
* STAT: Fired Members of the CDC Vaccine Advisory Committee: Americans Are Losing the Ability to Choose Vaccination (commentary) ([link removed]) (9/4/25)
* CNN: Florida Plans to End Vaccine Mandates Statewide, Including for Schoolchildren ([link removed]) (9/3/25)
* Washington Post: FDA Questions Common Practice of Getting COVID, Flu Vaccines Together ([link removed]) (9/3/25)
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* New York Times: Whistle-Blower Complaints Detail Tension Over Vaccines at N.I.H. ([link removed]) (9/4/25)
* Axios: Massachusetts Becomes First State to Impose Its Own Vaccine Coverage Rules ([link removed]) (9/4/25)
* WHYY: Pennsylvania Pharmacies Can Now Offer New COVID Vaccines After State Adopts Recommendations from Medical Societies ([link removed]) (9/3/25)
* New York Times: States Go Their Own (and Contradictory) Ways on Vaccine Policy ([link removed]) (9/3/25)
------------------------------------------------------------
Immunize.org Website and Clinical Resources
------------------------------------------------------------
Spotlight on the website: "Translations" web page simplifies access to our resources in 48 languages
Immunize.org offers translations of VISs and popular Patient Handouts. Our Translations web page ([link removed]) provides quick access to every translated resource on the Immunize.org website. Translations of one or more documents are available in 48 languages.
Languages are listed alphabetically in a simple table format. Next to the desired language, select either “VISs” or “Clinical Resources” to view all documents available in that language.
This "Translations" page is accessible from two menus at the top of each page: either the “Vaccines & VISs” or “Clinical Resources” menu. The direct link is www.immunize.org/translations ([link removed]).
Patients benefit from having vaccine information in their preferred language. Immunize.org's "Translations" page makes it easier for you to meet their needs.
------------------------------------------------------------
Recap: Immunize.org’s commitment to sharing clinical vaccination guidance based on the best available scientific evidence
The recent changes to the membership of ACIP and resignation of respected scientific leaders at CDC have raised serious concerns across public health and healthcare communities. Information shared by the departing CDC leaders has raised doubts about the scientific validity of vaccine policies contemplated by the current administration. In addition, we observed the June ACIP vote against the use of thimerosal-containing influenza vaccines, a decision made without following the standard rigorous review of available data or the structured evidence-to-recommendations framework. In response, professional medical societies (e.g., American Academy of Pediatrics, American College of Obstetricians and Gynecologists) have begun to issue vaccination guidance that differs from new CDC guidance. Vaccination providers and educators who depend on Immunize.org resources should understand how we are approaching this unprecedented situation.
First, Immunize.org will continue to ensure vaccination providers know what CDC and ACIP recommend. Their recommendations directly affect VFC, Medicaid, and Medicare vaccine coverage, and could impact other insurance plan coverage. Federal recommendations may also define the permitted scope of practice for some vaccinators, including pharmacists, depending upon state regulations. We will provide context to help our readers understand when available scientific evidence does not support federal guidance.
Second, we will continue to educate vaccinators and share the best available evidence-based clinical information and guidance for vaccination. This may include adding links to the recommendations and published schedules of professional societies or other broadly accepted clinical guidance organizations. When we update resources with guidance from other credible scientific sources, we will be explicit about where that guidance came from and connect you to those sources.
Our goal is to support you to be able to make the best possible clinical practice decisions and provide the best available vaccination advice to your patients and families. To this end, our popular standing orders templates will include CDC recommendations and, when needed, refer to major professional society recommendations where there are important differences. As always, our standing orders templates should be adapted as needed to develop the standing orders you use in specific settings.
Immunize.org is in the process of determining the best ways to reflect these differences on our website clearly and concisely. We commit to keeping you, our readers and partners, informed as we proceed. We remain committed to supporting you and members of the public with trustworthy vaccination information and resources.
------------------------------------------------------------
Recap: Immunize.org updates “Standing Orders for Administering Pfizer Respiratory Syncytial Virus (RSV) Vaccine (Abrysvo) During Pregnancy” to reference both preventive antibody options for infant RSV prevention
Immunize.org updated its Standing Orders for Administering Pfizer Respiratory Syncytial Virus (RSV) Vaccine (Abrysvo) During Pregnancy ([link removed]), to note the options to use nirsevimab (Beyfortus, Sanofi ([link removed]) ) or clesrovimab (Enflonsia, Merck) ([link removed]) for infant RSV protection if the mother was not effectively vaccinated during her pregnancy.
------------------------------------------------------------
Recap: Immunize.org updates “Meningococcal B Vaccine Recommendations by Age and Risk Factor” to include both pentavalent MenABCWY vaccine options
Immunize.org updated Meningococcal B Vaccine Recommendations by Age and Risk Factor ([link removed]) to add the second pentavalent MenABCWY vaccine (Penmenvy, GSK ([link removed]) [link removed]) in addition to Penbraya (Pfizer).
------------------------------------------------------------
Recap: Immunize.org updates resource “Before You Vaccinate Adults, Consider Their ‘H-A-L-O’!”
Immunize.org recently updated its popular resource for healthcare professionals titled Before You Vaccinate Adults, Consider Their “H-A-L-O” ([link removed])!
H-A-L-O refers to four factors:
* Health condition
* Age
* Lifestyle
* Occupation
Edits incorporate the age 50 threshold for adults with risk factors to receive RSV vaccine and referral to current recommendations for COVID-19 vaccine.
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Association of Immunization Managers offers handout compiling a variety of useful influenza vaccination resources
The Association of Immunization Managers ([link removed]) (AIM) posted Connecting the Dots: Influenza Vaccinations ([link removed]), a one-page resource guide designed to support influenza vaccination efforts. It conveniently lists several tools, helping users quickly access what they need. It is organized into three categories: health education, health communication, and program planning.
Connecting the Dots ([link removed]) will be updated monthly.
To find influenza resources from Immunize.org, see the Vaccines A–Z: Influenza ([link removed]) web page.
------------------------------------------------------------
New web page from CHOP's Vaccine Education Center provides links to the latest science-based vaccine recommendations
Children's Hospital of Philadelphia's ([link removed]) Vaccine Education Center ([link removed]) launched a new web page, Locating the Latest Science-Based Vaccine Recommendations ([link removed]), to assist in staying abreast of the latest science-based recommendations.
This one-stop web page ([link removed]) will be updated as recommendations change or as new statements from professional societies become available.
------------------------------------------------------------
Needle anxiety is common at any age. Use Immunize.org’s clinical resources to offer a positive vaccination experience.
In Clinical Resources: Improving the Vaccination Experience ([link removed]), Immunize.org provides print and video tools to create a positive vaccination experience and ease injection anxiety in children and adults. Links to additional resources from trusted partner organizations are also provided.
The web page links to eight printable resources ([link removed]) on addressing vaccination anxiety (four for providers, four for recipients—also available in Spanish), two in-depth webinars, and six brief videos (listed below). As with all Immunize.org resources, these are free to download, link, copy, and share.
The video topics include:
* How to Administer Multiple Intramuscular Vaccines to Adults During One Visit ([link removed])
* Using Enhanced Screening Checklists for Contraindications to Vaccination ([link removed])
* Addressing Vaccination Anxiety for Infants: Strategies for Vaccine Recipients and Caregivers ([link removed])
* Addressing Vaccination Anxiety: Strategies for Healthcare Professionals ([link removed])
* Fainting Related to Vaccination: What You Need to Know ([link removed])
* Addressing Vaccination Anxiety for Children: Strategies for Vaccine Recipients and Caregivers ([link removed])
Related Link
* Immunize.org: Clinical Resources: Improving the Vaccination Experience ([link removed]) web page
------------------------------------------------------------
Help Immunize.org reach more vaccinators through your social media networks. Follow us and share our posts on Facebook, Instagram, and LinkedIn!
Immunize.org offers a social media program to highlight our educational resources for a widespread audience of vaccinators. Our social media channels now feature our most popular printable resources and Ask the Experts questions, as well as announcements important to frontline vaccinators. Please view and share our newest feature, the Ask the Experts Video Series ([link removed]).
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise:
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at Immunize.org ([link removed])
* YouTube at ImmunizeOrg ([link removed])
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
“Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure—San Francisco, California, December 2024–January 2025” published in MMWR
CDC published Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure—San Francisco, California, December 2024–January 2025 ([link removed]) on September 4 in MMWR. A portion of the summary appears below.
As of January 1, 2025, 37 human cases of highly pathogenic avian influenza (HPAI) A(H5N1) had been detected in California, none of which occurred in San Francisco. . . .
On January 9, 2025, a case of HPAI A(H5N1) infection was identified in a school-aged child in San Francisco through enhanced surveillance (influenza A virus subtyping of a sample of specimens weekly). No source of exposure was identified, and investigations found no laboratory evidence of human-to-human transmission among close contacts. . . .
Enhanced surveillance and timely subtyping of a subset of influenza A–positive specimens, including specimens from persons without known A(H5N1) exposure, are important to detect avian influenza A virus infections. Public health investigations are critical to monitoring for human-to-human transmission.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]).
Related Link
* CDC: MMWR main page ([link removed]) providing access to the MMWR family of publications
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Today, virtual: Register for Immunize.org Website Office Hours. Join a 30-minute discussion about the VIS web section on September 10 at 4:00 p.m. (ET) or September 11 at 12:00 p.m. (ET). Recorded sessions archived.
To learn simple tips and tricks for using our website efficiently, please register for our next set of Website Office Hours on Wednesday, September 10, at 4:00 p.m. (ET) ([link removed]) or Thursday, September 11, at 12:00 p.m. (ET) ([link removed]). The same content will be covered in both sessions.
We will open each 30-minute session with a short, live demonstration on navigating the popular VIS website section on Immunize.org. You can submit questions when you register or live on Zoom during the session.
Register today for Immunize.org Website Office Hours (content is the same for both):
* Wednesday, September 10, at 4:00 p.m. (ET) ([link removed])
* Thursday, September 11, at 12:00 p.m. (ET) ([link removed])
The archive of previous Website Office Hours content ([link removed]) is posted at Immunize.org’s "Webinars & Videos" page.
Mark your calendar ([link removed]) for future Immunize.org Website Office Hours.
------------------------------------------------------------
Virtual: Watch CDC’s webinar “Clinician Update on Measles Cases and Outbreaks in the United States” on September 11 at 2:00 p.m. (ET); CE credit offered
CDC will host a 1-hour Clinician Outreach and Communication Activity (COCA) call titled Clinician Update on Measles Cases and Outbreaks in the United States ([link removed]) at 2:00 p.m. (ET) on September 11. Presenters will discuss the current epidemiology of measles in the United States and address common clinical questions about preventing, identifying, and testing for measles. Presenters will summarize MMR vaccination recommendations and considerations.
A recording of the COCA presentation will be archived on the COCA Calls web page ([link removed]).
Free CE credit (including CME, CPE, and CNE) will be offered for this COCA call.
------------------------------------------------------------
Virtual: North Dakota State University Center for Immunization Research and Education hosts webinar titled “Science to Practice: Protecting Children from Respiratory Viruses in 2025–2026” on September 16 at 1:00 p.m. (ET); CE credit offered
The North Dakota State University Center for Immunization Research and Education will host a webinar titled Science to Practice: Protecting Children from Respiratory Viruses in 2025–2026 ([link removed]), from 1:00 p.m. (ET) on September 16. This webinar will explore the latest trends in RSV, influenza, and COVID-19 in children, highlighting both established patterns and emerging threats.
Participants will gain insight into the key risk factors and vulnerable pediatric populations most at risk for severe outcomes, helping clinicians anticipate and manage complex cases with greater precision. Evidence-based prevention methods and current clinical recommendations will be discussed.
Free CME and CPE will be provided to live attendees.
Register for the webinar ([link removed]).
------------------------------------------------------------
Virtual: September 18–19 ACIP meeting announced; discussion and possible votes on COVID-19, hepatitis B, MMRV, and RSV vaccines planned
CDC is scheduled to convene the ACIP on September 18–19 ([link removed]). Based on ahttps://public-inspection.federalregister.gov/2025-16706.pdfnotice in the Federal Register ([link removed]), the meeting will discuss and potentially vote on COVID-19, hepatitis B, and MMRV vaccines and RSV preventive antibody products. An agenda has not yet been posted.
Written public comments ([link removed]) and registration for oral public comments must be received between September 2–13.
No registration is required to watch webcasts of live ACIP meetings or listen via telephone.
Related Links
* CDC: ACIP main page ([link removed]) for access to webcast, agendas
* CDC: ACIP Meeting Information ([link removed]) for presentation slides, content from previous meetings, and information about future meetings
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]).
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Gräbenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]).
IZ Express is supported in part by Grant No. NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer (http:// [link removed])
ISSN: 2771-8085
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp